The prevalence of exocrine pancreatic insufficiency in diabetes mellitus - a multicentre study.

A statistically significant ( p > 0.05) higher prevalence of pancreatic insufficiency was observed in patients with obesity (BMI > 25 kg/m 2 ).

However, no statistically significant association was found between FE-1 levels and factors such as diabetes duration, antidiabetic medication use, or metabolic control.

Pancreatic insufficiency is prevalent in diabetic patients, with a prevalence exceeding 20%.

The findings of this study support the rationale for screening for FE-1 in diabetes and suggest that enzyme replacement therapy may be a viable treatment option for patients diagnosed with pancreatic insufficiency.